Autism Spectrum Disorders
|
0.800 |
Biomarker
|
disease |
MGD |
|
|
|
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
HPO |
|
|
|
AUTISM, SUSCEPTIBILITY TO, 18
|
0.600 |
SusceptibilityMutation
|
disease |
CLINVAR |
|
|
|
Macrocephaly
|
0.490 |
Biomarker
|
disease |
HPO |
|
|
|
Intellectual Disability
|
0.490 |
Biomarker
|
group |
HPO |
|
|
|
Seizures
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Constipation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Flatfoot
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Orbital separation excessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sleep disturbances
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tall stature
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Downward slant of palpebral fissure
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Wide nose
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dyssomnias
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sleep Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Prominent supraorbital ridges
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Pointed chin
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Autism Spectrum Disorders
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
<i>CHD8</i> (chromodomain helicase DNA-binding protein 8), which codes for a member of the CHD family of ATP-dependent chromatin-remodeling factors, is one of the most commonly mutated genes in autism spectrum disorders (ASD) identified in exome-sequencing studies.
|
28321286 |
2017 |
Pervasive Development Disorder
|
0.070 |
GeneticVariation
|
group |
BEFREE |
Autism spectrum disorder early in development associated with CHD8 mutations among two Chinese children.
|
30376831 |
2018 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
Autism-associated CHD8 deficiency impairs axon development and migration of cortical neurons.
|
30574290 |
2018 |
Pervasive Development Disorder
|
0.070 |
Biomarker
|
group |
BEFREE |
CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors.
|
25294932 |
2014 |
Metastatic Prostate Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CHD8 expression was decreased in HGPIN, localized, and metastatic PCa compared to benign (P < .001).
|
25499215 |
2014 |
Metastasis from malignant tumor of prostate
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CHD8 expression was decreased in HGPIN, localized, and metastatic PCa compared to benign (P < .001).
|
25499215 |
2014 |
Malignant Neoplasms
|
0.040 |
PosttranslationalModification
|
group |
BEFREE |
CHD8 promoter hypermethylation, assessed by Quantitative Pyrosequencing, occurred in over 45% of primary cancers in this population as well as the TGCA database.
|
25499215 |
2014 |
Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
CHD8 outperformed Gleason score and predicted biochemical failure within intermediate grade prostate cancers.
|
25499215 |
2014 |